A Phase II International Multi-center Open label Proof o

Project: Research project

Description

A Phase II International Multi-center Open label Proof of concept study of BN83495 in Postmenapausal Women with Advanced Metastatic or Recurrent Oestrogen Receptor (ER) Positive Endometrial carcinoma who have received one line of Chemotherapy in the Adju
StatusFinished
Effective start/end date9/1/109/30/13

Funding

  • Ipsen Innovation

Fingerprint

Endometrial Neoplasms
Estrogen Receptors
Drug Therapy
irosustat